These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 19131783

  • 1. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
    Elenga N, Mialou V, Kebaïli K, Galambrun C, Bertrand Y, Pondarre C.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783
    [Abstract] [Full Text] [Related]

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 3. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galactéros F, Bierling P.
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [Abstract] [Full Text] [Related]

  • 4. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
    Hannema SE, Brand A, van Meurs A, Smiers FJ.
    Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
    [Abstract] [Full Text] [Related]

  • 5. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M, Heidemann SM, Sarnaik AP, Meert KL, Sarnaik SA.
    J Pediatr Hematol Oncol; 1999 Feb; 21(1):70-3. PubMed ID: 10029818
    [Abstract] [Full Text] [Related]

  • 6. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Bonin P, Rodet M, Chami B, Galacteros F, Bierling P, Noizat-Pirenne F.
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [Abstract] [Full Text] [Related]

  • 7. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR, Patel AR.
    South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885
    [Abstract] [Full Text] [Related]

  • 8. Delayed hemolytic transfusion reaction in sickle cell disease.
    Scheunemann LP, Ataga KI.
    Am J Med Sci; 2010 Mar; 339(3):266-9. PubMed ID: 20051821
    [Abstract] [Full Text] [Related]

  • 9. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S, Glasser CL.
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
    Win N, Sinha S, Lee E, Mills W.
    Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
    [Abstract] [Full Text] [Related]

  • 12. Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient.
    Delmonte L, Cantini M, Olivieri O, De Franceschi L.
    Transfusion; 2013 Mar; 53(3):688-9. PubMed ID: 23473065
    [No Abstract] [Full Text] [Related]

  • 13. Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease.
    McGlennan AP, Grundy EM.
    Anaesthesia; 2005 Jun; 60(6):609-12. PubMed ID: 15918834
    [Abstract] [Full Text] [Related]

  • 14. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM, Miller MJ, Chonat S, Stowell SR.
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [Abstract] [Full Text] [Related]

  • 15. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ.
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [Abstract] [Full Text] [Related]

  • 16. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K, Hoppe C, Mijovic A, Thein SL.
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [Abstract] [Full Text] [Related]

  • 17. Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
    Dean CL, Maier CL, Roback JD, Stowell SR.
    Transfusion; 2019 Feb; 59(2):448-453. PubMed ID: 30412270
    [Abstract] [Full Text] [Related]

  • 18. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV, Steane E, Cunningham G, Frenkel EP.
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [Abstract] [Full Text] [Related]

  • 19. Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.
    Mintz PD, Williams ME.
    Ann Clin Lab Sci; 1986 Nov; 16(3):214-8. PubMed ID: 3717883
    [Abstract] [Full Text] [Related]

  • 20. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
    Liem RI, O'Gorman MR, Brown DL.
    Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.